Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Control Release ; 193: 304-15, 2014 Nov 10.
Article in English | MEDLINE | ID: mdl-24780267

ABSTRACT

As a cationic polysaccharide, chitosan (CS) has been identified for its potential use as a non-viral vector for exogenous gene transfection. However, owing to their electrostatic interactions, CS complexes may cause difficulties in gene release upon their arrival at the site of action, thus limiting their transfection efficiency. In this work, an attempt is made to facilitate the release of a gene by incorporating a negatively-charged poly(γ-glutamic acid) (γPGA) into CS complexes in order to diminish their attractive interactions. The mechanisms of exploiting γPGA to enhance the transfection efficiency of CS complexes are elucidated. The feasibility of using this CS/γPGA-based system for DNA or siRNA transfer is explored as well. Additionally, potential of the CS/γPGA formulation to deliver disulfide bond-conjugated dual PEGylated siRNAs for multiple gene silencing is also examined. Moreover, the genetic use of pKillerRed-mem, delivered using complexes of CS and γPGA, to express a membrane-targeted KillerRed as an intrinsically generated photosensitizer for photodynamic therapy is described.


Subject(s)
Chitosan/chemistry , DNA/administration & dosage , Drug Carriers/chemistry , Endocytosis , Gene Transfer Techniques , Polyglutamic Acid/analogs & derivatives , RNA, Small Interfering/administration & dosage , Cell Line, Tumor , Cell Survival/genetics , Chitosan/pharmacology , DNA/genetics , DNA/pharmacokinetics , Drug Carriers/pharmacology , Drug Stability , Endocytosis/drug effects , Gene Silencing , Green Fluorescent Proteins/genetics , HEK293 Cells , Humans , Luciferases/genetics , Molecular Dynamics Simulation , Polyglutamic Acid/chemistry , Polyglutamic Acid/pharmacology , RNA, Small Interfering/genetics , RNA, Small Interfering/pharmacokinetics , Transfection
2.
Biomaterials ; 35(1): 500-8, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24112805

ABSTRACT

Photodynamic therapy (PDT) has received considerable attention as a therapeutic treatment for cancer and other diseases; however, it is frequently accompanied by prolonged phototoxic reaction of the skin due to slow clearance of synthetic photosensitizers (PSs) administered externally. This study was designed to investigate the genetic use of pKillerRed-mem, delivered using complexes of chitosan (CS) and poly(γ-glutamic acid) (γPGA), to intracellularly express a membrane-targeted KillerRed protein that can be used as a potential PS for PDT. Following transfection with CS/pKillerRed/γPGA complexes, a red fluorescence protein of KillerRed was clearly seen at the cellular membranes. When exposed to green-light irradiation, the KillerRed-positive cells produced an excessive amount of reactive oxygen species (ROS) in a time-dependent manner. Data from viability assays indicate that ROS have an important role in mediating KillerRed-induced cytotoxicity, apoptosis, and anti-proliferation, suggesting that KillerRed can be used as an intrinsically generated PS for PDT treatments. Notably, the phototoxic reaction of KillerRed toward cells gradually became negligible over time, presumably because of its intracellular degradability. These experimental results demonstrate that this genetically encoded KillerRed is biodegradable and has potential for PDT-induced destruction of diseased cells.


Subject(s)
Green Fluorescent Proteins/genetics , Photochemotherapy , Photosensitizing Agents/therapeutic use , Apoptosis/drug effects , Cell Proliferation/drug effects , Green Fluorescent Proteins/administration & dosage , HEK293 Cells , Humans , Photosensitizing Agents/pharmacology , Reactive Oxygen Species/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...